RightFit
RecruitingNot applicable

Connect-Home: Alzheimer's Disease and Related Dementias

Transitional Care for Skilled Nursing Facility Patients With Alzheimer's Disease and Related Dementias and Their Caregivers: a Cluster Randomized Trial

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
19 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests Connect-Home ADRD, a program that helps people with Alzheimer's disease or other dementias and their caregivers move from a skilled nursing facility to their next place of care. It will test whether the program lowers caregiver stress and improves patients' mood and behavior symptoms.

This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nursing Facility (SNF) patients with Alzheimer's disease and dementias and their caregivers during transitions from SNFs to home, assisted, living, and long-term care. The primary hypothesis is that the intervention will reduce caregiver strain (Aim 1) and patient neuropsychiatric symptoms (Aim 2).

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Patients must speak English.
  • Patients must plan to leave for home, assisted living, or long-term care.
  • Patients must have a diagnosis of dementia.
  • Patients must have a caregiver who is willing to join.
  • Caregivers must speak English.
  • Caregivers must have legal authority to make decisions for the patient and also provide support.
  • Skilled nursing facilities must be within 120 miles of UNC-Chapel Hill.
  • Skilled nursing facilities must admit at least 75 patients each year.

Who can't join

  • Patients cannot join if they plan to return to the hospital for a procedure or treatment within 30 days after joining.
  • Caregivers cannot join if they are a guardian chosen by a court.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: Patients: * Ability to speak English * Goal of discharge to home, assisted living, or long-term care * Diagnosis of dementia * Having a caregiver willing to participate Caregivers: * Ability to speak English * Legally authorized representative (LAR) who also provides support for the person with ADRD Inclusion criteria for SNFs: * Location within 120 miles of UNC-Chapel Hill * Admission of at least 75 SNF patients per year Exclusion Criteria: Patients: * Planned hospital readmission for procedures or treatments within 30 days post enrollment. Caregivers: * LAR is a court-appointed guardian.

Study sites (1)

NC